EDIGO BIOINFORMATICS Trademark

Trademark Overview

On Saturday, September 29, 2018, a trademark application was filed for EDIGO BIOINFORMATICS with the United States Patent and Trademark Office. The USPTO has given the EDIGO BIOINFORMATICS trademark a serial number of 88137290. The federal status of this trademark filing is REGISTERED as of Tuesday, June 2, 2020. This trademark is owned by EDIGENE INC. The EDIGO BIOINFORMATICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Medical and scientific research information in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics
edigo bioinformatics

General Information

Serial Number88137290
Word MarkEDIGO BIOINFORMATICS
Filing DateSaturday, September 29, 2018
Status700 - REGISTERED
Status DateTuesday, June 2, 2020
Registration Number6070251
Registration DateTuesday, June 2, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 5, 2019

Trademark Statements

Pseudo MarkEDI GO BIOINFORMATICS
NOT AVAILABLE"BIOINFORMATICS"
Goods and ServicesMedical and scientific research in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Medical and scientific research information in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, October 7, 2018
Primary Code042
First Use Anywhere DateTuesday, August 7, 2018
First Use In Commerce DateWednesday, August 8, 2018

Trademark Owner History

Party NameEDIGENE INC
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBEIJING 102206
CN
Party NameEDIGENE INC
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBEIJING 102206
CN
Party NameEDIGENE INC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBEIJING 102206
CN

Trademark Events

Event DateEvent Description
Wednesday, October 3, 2018NEW APPLICATION ENTERED
Thursday, December 6, 2018EXAMINER'S AMENDMENT ENTERED
Sunday, October 7, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 4, 2018ASSIGNED TO EXAMINER
Thursday, December 6, 2018EXAMINERS AMENDMENT -WRITTEN
Friday, December 7, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 28, 2018ASSIGNED TO LIE
Tuesday, February 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, December 6, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, December 6, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 16, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 5, 2019PUBLISHED FOR OPPOSITION
Tuesday, April 2, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, March 10, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 11, 2019TEAS STATEMENT OF USE RECEIVED
Thursday, October 17, 2019NON-FINAL ACTION E-MAILED
Thursday, October 17, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 21, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 11, 2019USE AMENDMENT FILED
Thursday, October 3, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 3, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 17, 2019SU - NON-FINAL ACTION - WRITTEN
Saturday, March 21, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, March 21, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, March 21, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Saturday, March 21, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, March 21, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, April 25, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 2, 2020REGISTERED-PRINCIPAL REGISTER
Monday, June 2, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 24, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, April 17, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 22, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 22, 2020TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

bioinformatics edigo gene research transcriptional modulation therapy editing genome scientific medical cell